Korean J Pain.  2019 Jul;32(3):178-186. 10.3344/kjp.2019.32.3.178.

Systemic effects of fluoroscopically guided epidural steroid injection with dexamethasone

• Kang WY
• Lee JW
• Lee E
• Kang Y
• Ahn JM
• Kang HS

• KMID: 2455613
• DOI: http://doi.org/10.3344/kjp.2019.32.3.178

Abstract

BACKGROUND
Epidural steroid injections (ESIs) have been widely used in managing spinal pain. Dexamethasone has recently emerged as a useful drug in this setting, relative to particulate steroids, although the associated systemic effects have not been fully elucidated. This study aimed to investigate the incidences and types of systemic effects after fluoroscopically guided ESI with dexamethasone.
METHODS
This retrospective study included 888 ESIs with dexamethasone (fluoroscopically guided at the cervical and lumbosacral levels) performed on 825 patients during January to June 2017. Data regarding systemic effects were collected via telephone interviews using a standardized questionnaire at 2 weeks after the procedure. Data on patient demographic, clinical, and procedural characteristics were collected and analyzed to identify factors that were associated with systemic effects. All statistical analyses were performed using the chi-squared test.
RESULTS
Among the 825 patients, 40 patients (4.8%) experienced systemic effects during the 2-week follow-up period. The most common systemic effect was facial flushing (12 patients, 1.5%), which was followed by urticaria (7 patients, 0.8%) and insomnia (7 patients, 0.8%). A history of spine surgery was significantly associated with the occurrence of systemic effects (P = 0.036). Systemic effects were significantly more common for injections at the cervical level than at the lumbar level (P = 0.019).
CONCLUSIONS
Approximately 4.8% of the patients who underwent ESI with dexamethasone experienced minor and transient systemic effects. These effects were more common in patients who had undergone a previous spine surgery or received a cervical ESI.

Keyword

Complications; Dexamethasone; Drug-Related Side Effects and Adverse Reactions; Epidural Space; Fluoroscopy; Incidence; Low Back Pain; Steroids

MeSH Terms

Dexamethasone*
Drug-Related Side Effects and Adverse Reactions
Epidural Space
Fluoroscopy
Flushing
Follow-Up Studies
Humans
Incidence
Interviews as Topic
Low Back Pain
Retrospective Studies
Sleep Initiation and Maintenance Disorders
Spine
Steroids
Urticaria
Dexamethasone
Steroids

Reference

1. Manchikanti L, Pampati V, Falco FJ, Hirsch JA. Assessment of the growth of epidural injections in the medicare population from 2000 to 2011. Pain Physician. 2013; 16:E349–64. PMID: 23877459.

2. McLain RF, Kapural L, Mekhail NA. Epidural steroid therapy for back and leg pain: mechanisms of action and efficacy. Spine J. 2005; 5:191–201. DOI: 10.1016/j.spinee.2004.10.046. PMID: 15749619.

3. Saal JS, Franson RC, Dobrow R, Saal JA, White AH, Goldthwaite N. High levels of inflammatory phospholipase A2 activity in lumbar disc herniations. Spine (Phila Pa 1976). 1990; 15:674–8. DOI: 10.1097/00007632-199007000-00011. PMID: 2218714.

4. Bensler S, Sutter R, Pfirrmann CW, Peterson CK. Long term outcomes from CT-guided indirect cervical nerve root blocks and their relationship to the MRI findings--a prospective Study. Eur Radiol. 2015; 25:3405–13. DOI: 10.1007/s00330-015-3758-4. PMID: 25903715.

5. Watts RW, Silagy CA. A meta-analysis on the efficacy of epidural corticosteroids in the treatment of sciatica. Anaesth Intensive Care. 1995; 23:564–9. DOI: 10.1177/0310057X9502300506. PMID: 8787255.

6. Epstein NE. The risks of epidural and transforaminal steroid injections in the spine: commentary and a comprehensive review of the literature. Surg Neurol Int. 2013; 4(Suppl 2):S74–93. DOI: 10.4103/2152-7806.109446. PMID: 23646278. PMCID: 3642757.

7. Botwin KP, Baskin M, Rao S. Adverse effects of fluoroscopically guided interlaminar thoracic epidural steroid injections. Am J Phys Med Rehabil. 2006; 85:14–23. DOI: 10.1097/01.phm.0000184475.44853.82. PMID: 16357544.

8. Botwin KP, Castellanos R, Rao S, Hanna AF, Torres-Ramos FM, Gruber RD, et al. Complications of fluoroscopically guided interlaminar cervical epidural injections. Arch Phys Med Rehabil. 2003; 84:627–33. DOI: 10.1016/S0003-9993(03)04862-1. PMID: 12736872.

9. Botwin KP, Gruber RD, Bouchlas CG, Torres-Ramos FM, Freeman TL, Slaten WK. Complications of fluoroscopically guided transforaminal lumbar epidural injections. Arch Phys Med Rehabil. 2000; 81:1045–50. DOI: 10.1053/apmr.2000.7166. PMID: 10943753.

10. Derby R, Lee SH, Kim BJ, Chen Y, Seo KS. Complications following cervical epidural steroid injections by expert interventionalists in 2003. Pain Physician. 2004; 7:445–9. PMID: 16858486.

11. Huston CW, Slipman CW, Garvin C. Complications and side effects of cervical and lumbosacral selective nerve root injections. Arch Phys Med Rehabil. 2005; 86:277–83. DOI: 10.1016/j.apmr.2004.02.018. PMID: 15706554.

12. Pobiel RS, Schellhas KP, Eklund JA, Golden MJ, Johnson BA, Chopra S, et al. Selective cervical nerve root blockade: prospective study of immediate and longer term complications. AJNR Am J Neuroradiol. 2009; 30:507–11. DOI: 10.3174/ajnr.A1415. PMID: 19193762.

13. Karaman H, Kavak GO, Tüfek A, Yldrm ZB. The complications of transforaminal lumbar epidural steroid injections. Spine (Phila Pa 1976). 2011; 36:E819–24. DOI: 10.1097/BRS.0b013e3181f32bae. PMID: 21217425.

14. Plastaras C, McCormick ZL, Garvan C, Macron D, Joshi A, Chimes G, et al. Adverse events associated with fluoroscopically guided lumbosacral transforaminal epidural steroid injections. Spine J. 2015; 15:2157–65. DOI: 10.1016/j.spinee.2015.05.034. PMID: 26065819.

15. McGrath JM, Schaefer MP, Malkamaki DM. Incidence and characteristics of complications from epidural steroid injections. Pain Med. 2011; 12:726–31. DOI: 10.1111/j.1526-4637.2011.01077.x. PMID: 21392252.

16. Manchikanti L, Malla Y, Wargo BW, Cash KA, Pampati V, Fellows B. A prospective evaluation of complications of 10,000 fluoroscopically directed epidural injections. Pain Physician. 2012; 15:131–40. PMID: 22430650.

17. El Abd O, Amadera J, Pimentel DC, Gomba L. Immediate and acute adverse effects following transforaminal epidural steroid injections with dexamethasone. Pain Physician. 2015; 18:277–86. PMID: 26000671.

18. Watkins TW, Dupre S, Coucher JR. Ropivacaine and dexamethasone: a potentially dangerous combination for therapeutic pain injections. J Med Imaging Radiat Oncol. 2015; 59:571–7. DOI: 10.1111/1754-9485.12333. PMID: 26076198.

19. Lee GY, Lee JW, Yeom JS, Kim KJ, Shin HI, Kang HS. The incidence of various types of systemic reactions related to epidural steroid injections: a prospective observational study. Korean J Radiol. 2018; 19:301–10. DOI: 10.3348/kjr.2018.19.2.301. PMID: 29520188. PMCID: 5840059.

20. Palmer WE. Spinal injections for pain management. Radiology. 2016; 281:669–88. DOI: 10.1148/radiol.2016152055. PMID: 27870618.

21. MacMahon PJ, Huang AJ, Palmer WE. Spine injectables: what is the safest cocktail? Am J Roentgenol. 2016; 207:526–33. DOI: 10.2214/AJR.16.16379. PMID: 27341350.

22. Schneider B, Zheng P, Mattie R, Kennedy DJ. Safety of epidural steroid injections. Expert Opin Drug Saf. 2016; 15:1031–9. DOI: 10.1080/14740338.2016.1184246. PMID: 27148630.

23. Goodman BS, Posecion LW, Mallempati S, Bayazitoglu M. Complications and pitfalls of lumbar interlaminar and transforaminal epidural injections. Curr Rev Musculoskelet Med. 2008; 1:212–22. DOI: 10.1007/s12178-008-9035-2. PMID: 19468908. PMCID: PMC2682416.

24. Derby R, Lee SH, Date ES, Lee JH, Lee CH. Size and aggregation of corticosteroids used for epidural injections. Pain Med. 2008; 9:227–34. DOI: 10.1111/j.1526-4637.2007.00341.x. PMID: 18298706.

25. MacMahon PJ, Eustace SJ, Kavanagh EC. Injectable corticosteroid and local anesthetic preparations: a review for radiologists. Radiology. 2009; 252:647–61. DOI: 10.1148/radiol.2523081929. PMID: 19717750.

26. Wright JM, Cowper JJ, Page Thomas DP, Knight CG. The hydrolysis of cortisol 21-esters by a homogenate of inflamed rabbit synovium and by rheumatoid synovial fluid. Clin Exp Rheumatol. 1983; 1:137–41. PMID: 6681133.

27. Dreyfuss P, Baker R, Bogduk N. Comparative effectiveness of cervical transforaminal injections with particulate and nonparticulate corticosteroid preparations for cervical radicular pain. Pain Med. 2006; 7:237–42. DOI: 10.1111/j.1526-4637.2006.00162.x. PMID: 16712623.

28. Friedly JL, Comstock BA, Heagerty PJ, Bauer Z, Rothman MS, Suri P, et al. Systemic effects of epidural steroid injections for spinal stenosis. Pain. 2018; 159:876–83. DOI: 10.1097/j.pain.0000000000001158. PMID: 29394207.

29. Gala FB, Aswani Y. Imaging in spinal posterior epidural space lesions: a pictorial essay. Indian J Radiol Imaging. 2016; 26:299–315. DOI: 10.4103/0971-3026.190406. PMID: 27857455. PMCID: 5036327.

30. Ahadian FM, McGreevy K, Schulteis G. Lumbar transforaminal epidural dexamethasone: a prospective, randomized, doubleblind, dose-response trial. Reg Anesth Pain Med. 2011; 36:572–8. DOI: 10.1097/AAP.0b013e318232e843. PMID: 22005659.

31. Everett CR, Baskin MN, Speech D, Novoseletsky D, Patel R. Flushing as a side effect following lumbar transforaminal epidural steroid injection. Pain Physician. 2004; 7:427–9. PMID: 16858483.